OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $3,058,799 | +1250.2% | 336,132 | +681.9% | 0.02% | +1600.0% |
| Q1 2023 | $226,552 | +13.3% | 42,989 | -10.8% | 0.00% | 0.0% |
| Q3 2022 | $200,000 | +25.0% | 48,210 | +20.8% | 0.00% | 0.0% |
| Q2 2022 | $160,000 | -3.0% | 39,896 | +20.0% | 0.00% | 0.0% |
| Q1 2022 | $165,000 | -87.1% | 33,240 | -81.9% | 0.00% | -91.7% |
| Q4 2021 | $1,277,000 | +39.7% | 183,234 | +100.5% | 0.01% | 0.0% |
| Q3 2021 | $914,000 | +165.7% | 91,369 | +276.8% | 0.01% | +200.0% |
| Q2 2021 | $344,000 | -5.0% | 24,246 | +38.7% | 0.00% | -20.0% |
| Q4 2020 | $362,000 | +65.3% | 17,487 | -39.4% | 0.01% | +66.7% |
| Q3 2020 | $219,000 | +40.4% | 28,838 | +54.1% | 0.00% | 0.0% |
| Q2 2020 | $156,000 | – | 18,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,784,850 | $15,064,000 | 62.56% |
| Versant Venture Management, LLC | 2,215,384 | $8,817,228,000 | 4.36% |
| SV Health Investors, LLC | 628,236 | $2,500,000 | 1.54% |
| DELTEC ASSET MANAGEMENT LLC | 724,747 | $2,885,000 | 0.80% |
| Endurant Capital Management LP | 232,727 | $926,000 | 0.49% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $1,011,000 | 0.15% |
| JGP Global Gestao de Recursos Ltda. | 12,568 | $50,000 | 0.06% |
| Man Group plc | 1,187,508 | $4,726,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 21,077 | $84,000 | 0.02% |
| NewEdge Advisors, LLC | 36,250 | $144,000 | 0.01% |